Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leticia Manen-Freixa
Observed name:
Manén Freixa, Leticia
Institutions:
Institute of Cancer Research,
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia
Observed institutions:
Institute of Cancer Research,
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia,
Institut Químic de Sarrià,
Universitat Ramon Llull
ORCID:
0000-0001-7077-7657
Observed ORCID:
0000-0001-7077-7657
OpenAlex ID:
A5028351565
Short-term exposure to environmental levels of nicotine and cotinine impairs visual motor response in zebrafish larvae through a similar mode of action: Exploring the potential role of zebrafish α7 nAChR
2023
·
Marina Bellot
, Leticia Manen-Freixa
, et al.
·
The Science of The Total Environment
·
19
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
2024
·
Leticia Manen-Freixa
, Albert A. Antolin
·
Expert Opinion on Drug Discovery
·
15
Deconstructing Markush: Improving the R&D Efficiency Using Library Selection in Early Drug Discovery
2022
·
Leticia Manen-Freixa
, José I. Borrell
, et al.
·
Pharmaceuticals
·
4
PDF
Exploring the unexplored chemical space: Rational identification of new Tafenoquine analogs with antimalarial properties
2024
·
Leticia Manen-Freixa
, Sonia Moliner-Cubel
, et al.
·
Bioorganic Chemistry
·
3
Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors
2025
·
Jacopo Boni
, Míriam Fernández-González
, et al.
·
The EMBO Journal
·
2
META-PRIME: Repurposing Drug Metabolites in Precision Oncology using AI
2025
·
Luca Ruvo
, Leticia Manen-Freixa
, et al.
PDF
Leveraging Cancer Drug Metabolites for Precision Drug Repurposing
2025
·
Albert A. Antolin
, Luca Ruvo
, et al.
PDF
Show more works
View as search
Works count:
8
Citation count:
43
H-index:
3
I10-index:
2
Year
Topic
Type